Te­va to pay $4.3B to set­tle opi­oid epi­dem­ic lit­i­ga­tion with states

Te­va and about a dozen states have agreed in prin­ci­ple to pay a max­i­mum of $4.25 bil­lion over 13 years (in­clud­ing the al­ready set­tled cas­es for about $550 mil­lion) to set­tle opi­oid-re­lat­ed lit­i­ga­tion that will al­so see the Is­raeli-based gener­ic man­u­fac­tur­er pay an­oth­er $100 mil­lion to Na­tive Amer­i­can tribes.

Spe­cif­ic de­tails of the set­tle­ment are still be­ing fi­nal­ized, sev­er­al state at­tor­neys gen­er­al said, al­though the agree­ment would fol­low the same struc­ture as pre­vi­ous opi­oid set­tle­ments, in­clud­ing the $26 bil­lion agree­ment with opi­oid dis­trib­u­tors and John­son & John­son.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER